Physician profile
Joseph E Tayar
NPI 1669792248
$725.50
in general payments reported to CMS, 2019-2025
10 companies · $20.11 in 2025
The $20.11 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $14.82 · 2021: $15.00 · 2022: $99.37 · 2024: $119 · 2025: $20.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $195.63 | 2019 | |
| Baxter Healthcare | $118.13 | 2022-2024 | Hillrom - Monarch Airway Clearance System |
| Vertex Pharmaceuticals Incorporated | $93.30 | 2019 | |
| Chiesi USA, INC. | $60.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $56.60 | 2019-2025 | Fasenra |
| Abbvie INC. | $55.29 | 2024 | |
| Resmed Corp | $48.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $47.99 | 2019 | |
| Philips North America LLC | $35.24 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Tayar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.